TABLE 5.
Case reports on the use of remimazolam besylate in clinical practice. NA = Not available/applicable, ECRP = Endoscopic retrograde cholangiopancreatography, MEP = Motor evoked potentials, EEG = electroencephalograph.
Procedure | Dose | Salt | Co-treatment | Comment | Ref |
---|---|---|---|---|---|
Spine surgery | Induction: 6 or 12 mg/kg/h; maintenance 0.5–1.5 mg/kg/h | Besylate | Remifentanil, rocuronium | MEP monitoring by EEG. Successful | Kondo et al. (2020) |
Craniotomy | Induction 12 mg/kg/h; maintenance 1 mg/kg/h | Besylate | Remifentanil, fentanyl | Awake when infusion stopped. Successful | Sato et al. (2020) |
ECRP | Induction 12 mg/kg/h; maintenance 1 mg/kg/h | Besylate | Remifentanil, rocuronium | High risk: Myotonic dystrophy. Successful | Fukuda et al. (2021) |
Cardiac surgery | Induction 6 mg/kg/h; maintenance 0.6–1 mg/kg/h | Besylate | Remifentanil, fentanyl, rocuronium | Cardiopulmonary bypass. Successful | Saito et al. (2021) |
Laminoplasty for spinal stenosis | Induction 12 mg/kg/h; maintenance 1 mg/kg/h | Besylate | Rocuronium | Re-sleeping observed after flumazenil reversal | Yamamoto et al. (2021b) |
Craniotomy | Induction 6 mg/kg/h; maintenance 0.75–1 mg/kg/h | Besylate | Remifentanil flumazenil | Awakening during surgery with flumazenil. Successful | Yoshida et al., (2021b) |
Craniotomy | NA | Besylate | NA | Concerns around pharyngeal reflex, blood pressure, and agitation on flumazenil reversal | Tachibana, Hayamizu and Yamakage, (2021) |
Surgery: 1) stent removal and 2) tumor resection | Initially 10 and 13 mg bolus respectively plus additional doses | Besylate | Remifentanil/fentanyl, rocuronium | Reduced effect in long-term benzodiazepine users | Yoshikawa et al. (2021) |
Cataract surgery, rigid laryngoscopy, bronchoscopy, intramedullary nailing, and hemiarthroplasty/hip fracture | 5–20 mg | Besylate | NA | Reduced impact on neuropsychiatric function compared to existing sedative agents | Henson and Thompson, (2021) |
Thyroid surgery | Induction 12 mg/kg/h; maintenance 1 mg/kg/h | Besylate | Remifentanil, rocuronium | Comparable anesthesia to existing drugs for neuromonitoring during thyroid surgery | Hayamizu et al. (2021) |
Hand surgery | Induction 6 mg/kg/h | Besylate | Remifentanil, fentanyl, rocuronium | Anaphylaxis to remimazolam | Tsurumi et al. (2021) |
MitraClip implantation in a patient with advanced heart failure | Induction 6 mg/kg/h; maintenance 0.15 mg/kg/h | Besylate | Remifentanil, rocuronium | Appropriate anesthetic management in a patient with severe cardiovascular disease | Satoh et al. (2021) |
Cochlear implant in a patient with mitochondrial encephalomyopathy | Induction 0.2 mg/kg (1 min); maintenance 1 mg/kg/h | Besylate | Remifentanil | Successful use for general anesthesia in a patient with mitochondrial myopathy | Suzuki, Doi and Nakajima, (2021) |